Copyright
©The Author(s) 2024.
World J Stem Cells. Dec 26, 2024; 16(12): 1022-1046
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1022
Published online Dec 26, 2024. doi: 10.4252/wjsc.v16.i12.1022
Figure 4 Bone marrow mesenchymal stem cellmiR-540-3p-mimic exosomes reduces immune resistance in dendritic cells.
A-D: Flow cytometry analysis of the positive rate of cell surface markers in dendritic cells (major histocompatibility complex II, CD80, CD86, and CD274) for 72 hours; E-H: Enzyme-linked immunosorbent assay-based quantitative analysis of cytokine production (interleukin-1β, interferon-γ, interleukin-10, transforming growth factor β1) in dendritic cells. aP < 0.05, dP < 0.0001. MHC: Major histocompatibility complex; BMSC: Bone marrow mesenchymal stem cell; IDO: Indoleamine 2,3-dioxygenase; DC: Dendritic cell; LPS: Lipopolysaccharide; exo: Exosomes; IL: Interleukin; TGF: Transforming growth factor; IFN: Interferon.
- Citation: He JG, Wu XX, Li S, Yan D, Xiao GP, Mao FG. Exosomes derived from microRNA-540-3p overexpressing mesenchymal stem cells promote immune tolerance via the CD74/nuclear factor-kappaB pathway in cardiac allograft. World J Stem Cells 2024; 16(12): 1022-1046
- URL: https://www.wjgnet.com/1948-0210/full/v16/i12/1022.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v16.i12.1022